Literature DB >> 33454969

Eradicating cervical cancer: Lessons learned from Rwanda and Australia.

Julia Kramer1.   

Abstract

Both Rwanda and Australia have made significant strides to eradicate cervical cancer. To understand the successes in Rwanda and Australia, a comparative policy analysis was conducted based on key informant interviews and a review of peer-reviewed literature and policy briefs. Notable findings were identified that offer lessons for countries across the income spectrum. To address cervical cancer, low- and middle-income countries can leverage foreign aid, international collaboration, and strong political advocacy, as Rwanda did. High-income countries can invest in translational research that builds capacity from basic science research to implementation of novel and impactful health products and services, as Australia did. All countries can consider rolling out HPV vaccination by targeting the social and/or physical environment (e.g., a school-based vaccination program, as both Rwanda and Australia did). Cervical cancer is preventable, and eradication is within reach for countries across the income spectrum around the world. Cervical cancer screening programs are needed to minimize the incidence of and mortality from cervical cancer in the short term, and HPV vaccination programs are the best strategy to eradicate cervical cancer in the long term.
© 2021 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Australia; HPV vaccination; Rwanda; cervical cancer; cervical cancer screening; policy analysis

Mesh:

Substances:

Year:  2021        PMID: 33454969     DOI: 10.1002/ijgo.13601

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

1.  Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.

Authors:  Lili Song; Shikai Liu; Sufen Zhao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 2.  Thousands of Women's Lives Depend on the Improvement of Poland's Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities.

Authors:  Marcin Śniadecki; Patryk Poniewierza; Paulina Jaworek; Ada Szymańczyk; Gorm Andersson; Maria Stasiak; Michał Brzeziński; Małgorzata Bońkowska; Magdalena Krajewska; Joanna Konarzewska; Dagmara Klasa-Mazurkiewicz; Paweł Guzik; Dariusz Grzegorz Wydra
Journal:  Diagnostics (Basel)       Date:  2022-07-26

3.  Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the Global Burden of Disease.

Authors:  Meng Yang; Juan Du; Hui Lu; Feiyan Xiang; Hong Mei; Han Xiao
Journal:  BMJ Open       Date:  2022-07-22       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.